Literature DB >> 29870699

Alzheimer's disease.

Gøril Rolfseng Grøntvedt1, Tobias Navarro Schröder2, Sigrid Botne Sando3, Linda White3, Geir Bråthen3, Christian F Doeller4.   

Abstract

The German psychiatrist and neuropathologist Alois Alzheimer was fascinated by the symptoms of Auguste D., a 50-year-old woman admitted to the Frankfurt Psychiatric Hospital in 1901 who suffered from memory disturbances, paranoia and progressive confusion. After her death and autopsy, Alzheimer described histological alterations in her brain that later came to be known as amyloid plaques and neurofibrillary tangles (Figure 1). The case report was published in a psychiatric textbook some years later, and this peculiar and (at the time) seemingly rare illness was later named Alzheimer's disease.
Copyright © 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29870699     DOI: 10.1016/j.cub.2018.04.080

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  9 in total

Review 1.  Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases.

Authors:  Tanja Patricia Eicher; M Hasan Mohajeri
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

2.  Platelet biomarkers for a descending cognitive function: A proteomic approach.

Authors:  Haitao Yu; Yanchao Liu; Benrong He; Ting He; Chongyang Chen; Jiahua He; Xifei Yang; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2021-05-04       Impact factor: 9.304

3.  Tetramethylpyrazine Improves Cognitive Impairment and Modifies the Hippocampal Proteome in Two Mouse Models of Alzheimer's Disease.

Authors:  Xianfeng Huang; Jinyao Yang; Xi Huang; Zaijun Zhang; Jianjun Liu; Liangyu Zou; Xifei Yang
Journal:  Front Cell Dev Biol       Date:  2021-03-15

Review 4.  Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?

Authors:  Serena Silvestro; Andrea Valeri; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

5.  Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice.

Authors:  Min Luo; Qinghua Zeng; Kai Jiang; Yueyang Zhao; Zhimin Long; Yexiang Du; Kejian Wang; Guiqiong He
Journal:  Genes Dis       Date:  2021-02-16

6.  Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.

Authors:  Arubala P Reddy; Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Lloyd E Bunquin; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

7.  Knowledge and perceptions of Alzheimer's disease in three ethnic groups of younger adults in the United Kingdom.

Authors:  Aysegul Humeyra Kafadar; Christine Barrett; Kei Long Cheung
Journal:  BMC Public Health       Date:  2021-06-12       Impact factor: 3.295

Review 8.  Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease.

Authors:  Andrea Castaneda; Ricardo Ferraz; Mónica Vieira; Isabel Cardoso; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2021-06-16       Impact factor: 5.118

9.  Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.

Authors:  Ramona Belfiore; Alexis Rodin; Eric Ferreira; Ramon Velazquez; Caterina Branca; Antonella Caccamo; Salvatore Oddo
Journal:  Aging Cell       Date:  2018-11-28       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.